E Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
|
|||||
|
2025
Q1 | $311K | Buy |
|
|||||
|
2024
Q4 | $195K | Sell |
|
|||||
|
2024
Q3 | $282K | Sell |
|
|||||
|
2024
Q2 | $301K | Buy |
|
|||||
|
2024
Q1 | $342K | Sell |
|
|||||
|
2023
Q4 | $717K | Buy |
|
|||||
|
2023
Q3 | $360K | Sell |
|
|||||
|
2023
Q2 | $433K | Sell |
|
|||||
|
2023
Q1 | $355K | Sell |
|
|||||
|
2022
Q4 | $464K | Buy |
|
|||||
|
2022
Q3 | $448K | Buy |
|
|||||
|
2022
Q2 | $361K | Buy |
|
|||||
|
2022
Q1 | $280K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $177K | Buy |
|